Shockwave Medical's REDUCER-I study shows positive real-world outcomes for its novel technology, the Shockwave Reducer, in treating refractory angina.
Shockwave Medical's REDUCER-I study presents positive real-world outcomes for its novel technology, the Shockwave Reducer, in treating refractory angina. The post-market, multi-center observational study involved 400 patients and showed consistent and sustained benefits at six months and up to three years. Results were presented at the American College of Cardiology's Annual Scientific Session.
April 08, 2024
6 Articles